Boster Immunoleader

antibody

Anti-VIP Receptor 1 Antibody

PA1756

100 ug/vial

200 USD

polyclonal

rabbit

human, mouse

Anti-VIP Receptor 1 Antibody

PA1756

Polyclonal

Rabbit IgG polyclonal antibody for Vasoactive intestinal polypeptide receptor 1(VIPR1) detection. Tested with WB in Human;Mouse;Rat.

200 USD

Rabbit IgG

100 ug/vial

Lyophilized

No cross reactivity with other proteins.

Reacts with: human Predicted to work with: mouse, rat

WB

Concentration: 0.1-0.5μg/ml; Tested Species: Human; Predicted Species: Mouse, Rat

Tested Species: In-house tested species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities. Other applications have not been tested. Optimal dilutions should be determined by end users.

A synthetic peptide corresponding to a sequence at the C-terminus of human VIP Receptor 1(400-414aa RRKWRRWHLQGVLGW), identical to the related rat and mouse sequences.

Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3.

Immunogen affinity purified.

Add 0.2ml of distilled water will yield a concentration of 500ug/ml.

At -20˚C for one year. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for a longer time. Avoid repeated freezing and thawing.

Boster provides a series of assays reacted with primary antibodies. Antibody can be supported by chemiluminescence kit EK1002 in WB.

VIPR1(Vasoactive intestinal polypeptide receptor 1), also known as VIPR,HVR1, is a protein that in humans is encoded by the VIPR1 gene. Distinct subsets of neural, respiratory, gastrointestinal, and immune cells bear specific high-affinity G protein-coupled receptors for VIP, such as VIPR1. The VIPR1 gene is mapped on 3p22.1. The VIPR1 gene was found to span approximately 22 kb and to be comprised of 13 exons(ranging from 42 to 1,400 bp) and 12 introns(ranging from 0.3 to 6.1 kb). One encodes a VIP receptor consisting of 460 amino acids and having 7 putative transmembrane domains, as do other G protein-coupled receptors. Patients with idiopathic achalasia show a significant difference in the distribution of SNPs affecting VIPR1.

1. Couvineau, A., Rouyer-Fessard, C., Darmoul, D., Maoret, J.-J., Carrero, I., Ogier-Denis, E., Laburthe, M. Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200: 769-776, 1994. 2. Sreedharan, S. P., Huang, J.-X., Cheung, M.-C., Goetzl, E. J. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Nat. Acad. Sci. 92: 2939-2943, 1995.

VIPR1

Vasoactive intestinal polypeptide receptor 1(VIP-R-1)

vasoactive intestinal peptide receptor 1

FLJ41949 antibody HVR 1 antibody HVR1 antibody PACAP R 2 antibody PACAP type II receptor antibody PACAP-R-2 antibody PACAP-R2 antibody Pituitary adenylate cyclase activating polypeptide receptor type II antibody Pituitary adenylate cyclase activating polypeptide type II receptor antibody Pituitary adenylate cyclase-activating polypeptide type II receptor antibody RCD1 antibody RDC 1 antibody RDC1 antibody V1RG antibody VAPC 1 antibody VAPC1 antibody Vasoactive intestinal peptide receptor 1 antibody Vasoactive intestinal polypeptide receptor 1 antibody Vasoactive intestinal polypeptide receptor 1 precursor antibody VIP R 1 antibody VIP receptor type I antibody VIP-R-1 antibody VIPR 1 antibody VIPR antibody VIPR1 antibody VIPR1_HUMAN antibody VIRG antibody VPAC 1 antibody VPAC1 antibody VPCAP1R antibody

P32241